-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Applied Genetic Technologies Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2017 to Q3 2022.
- Applied Genetic Technologies Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2022 was $7.14M, a 50879% increase year-over-year.
- Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.08M, a 91.1% decline from 2021.
- Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $79.6M, a 77% increase from 2020.
- Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2020 was $45M, a 66049% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)